Compare Edwards Lifesciences Corporation Common Stock (EW) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Keysight Technologies Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.78 (market cap $48.56B), while Keysight Technologies Inc trades at $379.9 (market cap $63.79B). The key difference: Keysight Technologies Inc is the larger of the two by market cap, and Keysight Technologies Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | KEYS | |
|---|---|---|
Market Cap | $48.56B | $63.79B |
Volume | 6,520,488 | 1,435,384 |
Sector | Health | Technology |
52-Week High | $95.18 | $387.90 |
52-Week Low | $72.65 | $159.49 |
Enterprise Value | $45.01B | $63.93B |
Typical Hold Time | — | 56 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KEYS trades at $381.49, down 1.65% on the day, with a bullish technical signal from moving averages and strong fundamental performance including three consecutive quarterly earnings beats. Revenue for 2025 reached $5.38 billion with a net income margin of 19.14%, while analyst consensus is strongly bullish with an 81.25% buy rating and a $416.63 price target. Recent news highlights growth in AI infrastructure and 6G technology development.
The outlook for KEYS is positive, driven by accelerating earnings and expanding AI and 6G opportunities, though high valuation multiples and supply chain constraints present risks. Upside potential exists if the company continues to exceed earnings expectations and capitalize on tech sector demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
